Skip to main content
INSMED Inc logo

INSMED Inc — Investor Relations & Filings

Ticker · INSM ISIN · US4576693075 LEI · 529900Q55QAG41CCAC11 US Manufacturing
Open in API
Filings indexed 1,323 across all filing types
Latest filing 2019-04-08 Earnings Release
Country US United States of America
Listing US INSM

About INSMED Inc

https://insmed.com/

Insmed Incorporated is a global biopharmaceutical company dedicated to developing and commercializing therapies for patients with serious and rare diseases. The company's primary focus is on addressing areas of high unmet medical need. Its marketed product, Arikayce (liposomal amikacin for inhalation), is a treatment for Mycobacterium avium complex (MAC) lung disease. Insmed leverages proprietary technologies, such as its advanced liposomal pulmonary delivery system, to create novel treatments. The company maintains a diverse pipeline of investigational medicines and is actively advancing potential new therapies through various stages of clinical trials.

Recent filings

Filing Released Lang Actions
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 8, 2019, by Insmed Incorporated. It announces preliminary net product sales for the quarter ended March 31, 2019, and includes a press release as an exhibit. The document explicitly states that the information is furnished pursuant to Item 2.02 (Results of Operation and Financial Condition) and is not filed for purposes of Section 18 of the Exchange Act. The length is 3614 characters, which is relatively short and primarily serves as an announcement of financial results rather than a full financial report. It does not contain detailed financial statements or substantive financial data but rather a press release summary. According to the rules, such documents are classified as Earnings Release (ER) since they announce quarterly financial results highlights. Therefore, the appropriate classification is ER with high confidence.
2019-04-08 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. It includes information about the upcoming Annual Meeting, voting instructions, and details on items to be voted on such as election of directors, advisory vote on executive compensation, ratification of auditors, and approval of an incentive plan. The document is not the actual proxy statement report but rather additional materials related to the proxy solicitation. The presence of terms like 'Definitive Additional Materials' and instructions on how to vote confirm this is proxy solicitation material. According to the filing definitions, Proxy Solicitation & Information Statement (PSI) covers materials sent to shareholders to provide information and request votes for meetings. Therefore, this document fits best under the Proxy Solicitation & Information Statement category (PSI). The document length (6379 characters) and content confirm it is not a brief announcement or a full annual report but proxy materials. Confidence is high due to clear identification of the SEC form and content type.
2019-04-04 English
DEF 14A
Proxy Solicitation & Information Statement
2019-04-04 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated March 27, 2019. The key content is the announcement of the departure of a Chief Financial Officer and the commencement of a search for a successor. This corresponds to a change in senior management. There is no financial data or report attached, and the document is relatively short (3840 characters). The primary focus is on management changes, which fits the category of Board/Management Information (MANG).
2019-03-27 English
Regulatory Filings 2019
Regulatory Filings
2019-03-18 English
PRIMARY DOCUMENT
Director's Dealing
2019-02-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.